Camena Bioscience - Crunchbase Company Profile & Funding

Q: Who invested in Camena Bioscience?

Camena Bioscience has 2 investors including John McCafferty And Mercia Asset Management.

Q: When was the last funding round for Camena Bioscience?

Camena Bioscience closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Camena Bioscience raised to date?

Camena Bioscience has raised obfuscated.

Overview

Camena Bioscience

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Camena Bioscience

CB Rank

48355

Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications.

Founded

obfuscation

Private

Venture - Series Unknown

Cambridge, Cambridgeshire, United Kingdom

11-50

www.camenabio.com/

Biotechnology

Health Care

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Nagesh K. Mahanthappa: Non Executive Director
Past Role: Exo Therapeutics, Independent Director
Derek Stemple: CTO and Co-Founder

Details

Legal Name

Camena Bioscience Inc.

Operating Status

Active

Company Type

For Profit

Founders

Andy Fraser, Derek Stemple, Steve Harvey

About the Company

Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications. It has engineered new nucleic acid synthesis technology which improves the quality and speed of synthesis. Its multi-enzymatic technology takes one approach to DNA, RNA, and XNA synthesis, offering increased accuracy over existing

Phosphoramidite synthesis technology.

Camena Bioscience was founded in 2016 and is headquartered in Cambridge.

Contact Email

info@camenabio.com

Predictions & Insights

Growth Insight

See this Growth Insight

Camena Bioscience is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

gSynth® Platform

An enzymatic DNA synthesis technology enabling accurate production of long, complex synthetic DNA sequences without the need for codon optimization.

GreenSynth Reagents

Chemical reagents designed to support environmentally friendly DNA synthesis processes by eliminating harmful chemicals.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Camena Bioscience	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Camena Bioscience	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Camena Bioscience	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Camena Bioscience	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Camena Bioscience	2	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Camena Bioscience	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Camena Bioscience	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Camena Bioscience	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Camena Bioscience	2	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Camena Bioscience	2	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
John McCafferty	—	Venture Round - Camena Bioscience	—
John McCafferty	—	Venture Round - Camena Bioscience	—
John McCafferty	—	Venture Round - Camena Bioscience	—
John McCafferty	—	Venture Round - Camena Bioscience	—
John McCafferty	—	Venture Round - Camena Bioscience	—